NP_001081471.1
[Other Products]
NCBI GenBank Nucleotide #
|
[Other Products]
UniProt Primary Accession #
|
[Other Products]
UniProt Related Accession #
Molecular Weight
42,134 Da
NCBI Official Full Name
beta-1,3-N-acetylglucosaminyltransferase lunatic fringe
NCBI Official Synonym Full Names
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase S homeolog
NCBI Official Synonym Symbols
NCBI Protein Information
beta-1,3-N-acetylglucosaminyltransferase lunatic fringe
UniProt Protein Name
Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe
UniProt Synonym Protein Names
O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
UniProt Comments for lfng
Glycosyltransferase that initiates the elongation of O-linked fucose residues attached to EGF-like repeats in the extracellular domain of Notch molecules. Essential mediator of somite segmentation and patterning (). May be involved in mesoderm development (PubMed:8662522).
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Pathways associated with lfng recombinant protein
Diseases associated with lfng recombinant protein
Disease Name |
Pubmed Publications |
Abnormalities, Multiple Antibodies |
>14 publications with lfng and Abnormalities, Multiple |
Congenital Abnormalities Antibodies |
>12 publications with lfng and Congenital Abnormalities |
Disease Models, Animal Antibodies |
>8 publications with lfng and Disease Models, Animal |
Nervous System Diseases Antibodies |
>5 publications with lfng and Nervous System Diseases |
Cardiovascular Diseases Antibodies |
>4 publications with lfng and Cardiovascular Diseases |
Infertility, Female Antibodies |
>2 publications with lfng and Infertility, Female |
Nervous System Malformations Antibodies |
>2 publications with lfng and Nervous System Malformations |
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE Antibodies |
>2 publications with lfng and SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE |
Abnormalities, Drug-Induced Antibodies |
>1 publications with lfng and Abnormalities, Drug-Induced |
Inflammation Antibodies |
>1 publications with lfng and Inflammation |
Organs/Tissues associated with lfng recombinant protein
|